Annual Cash & Cash Equivalents
$2.58B$144.70M-5.31%
Summary
- Current Value
- As of today, DXCM annual cash & cash equivalents is $2.58B, down -5.31% on
- Historical Performance
- DXCM annual cash & cash equivalents is down -5.56% over the past 3 years, and up +68.23% over the past 5 years
- All-Time High Comparison
- DXCM annual cash & cash equivalents is currently -5.56% below its historical high of $2.73B set on
- 3-Year Low Comparison
- DXCM annual cash & cash equivalents is +5.02% above its 3-year low of $2.46B reached on an earlier date
- Sector Comparison
- DXCM annual cash & cash equivalents is higher than 96.68% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $2.58B | -5.3% | -5.6% | +68.2% | – | |
| Quarterly Cash & Cash Equivalents | $3.32B | +33.3% | +40.1% | +27.6% | +10000.0% | |
| Price | $72.86 | -16.9% | -31.5% | -21.3% | +1923.9% | |
| Annual Current Assets | $4.30B | -2.8% | +16.8% | +118.4% | +10000.0% | |
| Annual Total Liabilities | $4.38B | +4.4% | +51.6% | +189.7% | +6600.9% | |
| Annual Working Capital | $1.37B | -52.3% | -53.8% | -14.9% | +7455.7% | |
| Annual Net Income | $576.20M | +6.4% | +165.7% | +469.9% | +1176.5% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.72B | -5.3% | |
| 5Y | $2.73B | -5.6% | |
| All | $2.73B | -5.6% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.46B | N/A | +5.0% |
| 5Y | $2.46B | +5.0% | |
| All | $7.78M | >+9999.0% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of DXCM?
As of today, DXCM annual cash & cash equivalents is $2.58B
What is 1-year change in DXCM annual cash & cash equivalents?
DXCM annual cash & cash equivalents is down -5.31% year-over-year
What is 3-year change in DXCM annual cash & cash equivalents?
DXCM annual cash & cash equivalents is down -5.56% over the past 3 years
How far is DXCM annual cash & cash equivalents from its all-time high?
DXCM annual cash & cash equivalents is currently -5.56% below its historical high of $2.73B set on December 31, 2021
How does DXCM annual cash & cash equivalents rank versus sector peers?
DXCM annual cash & cash equivalents is higher than 96.68% of companies in Healthcare sector
When is DXCM next annual earnings release?
The next annual earnings release for DXCM is on
Quarterly Cash & Cash Equivalents
$3.32B$392.80M+13.41%
Summary
- Current Value
- As of today, DXCM quarterly cash & cash equivalents is $3.32B, up +13.41% on
- Historical Performance
- DXCM quarterly cash & cash equivalents is up +33.29% year-over-year, and up +40.06% over the past 3 years
- All-Time High Comparison
- DXCM quarterly cash & cash equivalents is currently -8.64% below its historical high of $3.64B set on
- 3-Year Low Comparison
- DXCM quarterly cash & cash equivalents is +35.25% above its 3-year low of $2.46B reached on an earlier date
- Sector Comparison
- DXCM quarterly cash & cash equivalents is higher than 96.74% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $3.32B | +13.4% | +33.3% | +40.1% | +27.6% | |
| Annual Cash & Cash Equivalents | $2.58B | – | -5.3% | -5.6% | +68.2% | |
| Price | $72.86 | +2.5% | -16.9% | -31.5% | -21.3% | |
| Quarterly Current Assets | $5.22B | +3.8% | +22.4% | +53.6% | +61.2% | |
| Quarterly Total Liabilities | $4.77B | +0.4% | +9.1% | +55.3% | +104.5% | |
| Quarterly Working Capital | $1.88B | +9.4% | -25.5% | -24.6% | -31.0% | |
| Quarterly Net Income | $283.80M | +57.8% | +110.8% | +180.4% | +293.1% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.32B | at high | |
| 3Y | $3.64B | -8.6% | |
| 5Y | $3.64B | -8.6% | |
| All | $3.64B | -8.6% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.58B | N/A | +28.8% |
| 3Y | $2.46B | N/A | +35.3% |
| 5Y | $2.37B | +40.1% | |
| All | $4.64M | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of DXCM?
As of today, DXCM quarterly cash & cash equivalents is $3.32B
What is DXCM quarterly cash & cash equivalents most recent change?
DXCM quarterly cash & cash equivalents was up +13.41% on September 30, 2025
What is 1-year change in DXCM quarterly cash & cash equivalents?
DXCM quarterly cash & cash equivalents is up +33.29% year-over-year
How far is DXCM quarterly cash & cash equivalents from its all-time high?
DXCM quarterly cash & cash equivalents is currently -8.64% below its historical high of $3.64B set on June 30, 2023
How does DXCM quarterly cash & cash equivalents rank versus sector peers?
DXCM quarterly cash & cash equivalents is higher than 96.74% of companies in Healthcare sector
When is DXCM next earnings release?
The next earnings release for DXCM is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- DXCM Official Website www.dexcom.com/global
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1093557/000109355725000280/0001093557-25-000280-index.htm
- DXCM Profile on Yahoo Finance finance.yahoo.com/quote/DXCM
- DXCM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dxcm